Urinary Tract Infection(UTI)IUTICNCT07485686
Multicentre Prospective Observational Cohort Study Aiming to Collect Medical Data, Create a Database to Facilitate Clinical and Fundamental Research Into Urinary Tract Infections With the Ultimate Goal of Improving Their Treatment.
An observational study of Urinary Tract Infection(UTI) and Urinary Tract Infection, Recurrent, run by Angela HUTTNER at 5 sites in 3 countries.
Trial summary
The goal of this prospective observational study is to collect epidemiological, clinical, microbiological, genetic, and behavioral data on individuals with UTIs. The goal is to better understand which interventions are effective and, subsequently, to facilitate studies that will improve our understanding of the… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Urinary Tract Infection(UTI), Urinary Tract Infection, Recurrent, UTI - Urinary Tract Infection
- How many people
- 500 participants
- Where
- 5 sitesin 3 countries
- Study dates
- 6 Jun 2023to Jan 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All patients of any age or disposition (in- or outpatient) with a history of, or active, urinary symptoms suggestive of UTI or diagnosed with UTI are eligible for inclusion into SUTIC. Adult (≥18 years) sexual partners of included patients are also eligible.
Who may be able to join
- Urinary symptoms/signs suggestive of UTI (as determined by investigators), or a history of such symptoms/signs.
Who cannot join
- Unwillingness to provide informed consent (for patients with capacity or for the representatives of those without capacity) and/or inability to provide informed consent (for patients without capacity and without representation).
Trial locations and contacts
5 sites in 3 countries. Contact the study team or a site near you to ask about taking part.
5 sites in 3 countries
Switzerland3 sites
Universitäts-Kinderspital beider Basel
Basel
Hôpitaux Universitaires de Genève
Geneva, Canton of Geneva, 1205
Universitätsspital Zürich
Zurich
About this study
Official title: The International Urinary Tract Infection Cohort
The goal of this prospective observational study is to collect epidemiological, clinical, microbiological, genetic, and behavioral data on individuals with UTIs. The goal is to better understand which interventions are effective and, subsequently, to facilitate studies that will improve our understanding of the condition, enhance patient care and relief, and help combat antimicrobial resistance. This project will enable us to study episodes of urinary tract infections over a period of at least 2 years and up to 5 years.
- Conditions
- Urinary Tract Infection(UTI), Urinary Tract Infection, Recurrent, UTI - Urinary Tract Infection
- Keywords
- uti, cohort, urinary tract infections, observational cohort
- Medical subject headings
- Urinary Tract Infections
What is being measured
The primary outcome is the main question the study is designed to answer.
Total number of suspected and microbiologically confirmed urinary tract infections.
Yearly incidence of suspected and microbiologically confirmed UTI at 12 months among all patients initially presenting with lower urinary tract symptoms (LUTS) or upper urinary tract symptoms (UUTS).
Measured: From enrollment for a minimum of two years and a maximum of five years, with data collection at regular time points (2 months, 6 months, 12 months, 18 and 24 months after enrollment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Mar 2026
- Study start6 Jun 2023
- Primary completionDec 2028 (estimated)
- Study completionJan 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Urinary Tract Infection(UTI)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Angela HUTTNER
- Sponsor type
- University, hospital or other
- Collaborators
- University Hospital, Geneva
- Responsible party
- Sponsor-investigator, Angela HUTTNER, University of Geneva, Switzerland
- Investigators
- Angela Huttner, MD, Principal investigator, Geneva University Hospitals, Geneva Faculty of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07485686
- Sponsor's protocol ID
- CCER 2023-00332
- Other IDs
- Agreement number: 2155009966
- Acronym
- IUTIC
- Status last verified
- Mar 2026
- First submitted
- 16 Mar 2026
- Last updated
- 20 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The International Urinary Tract Infection Cohort
- ClinicalTrials.gov ID
- NCT07485686
- Acronym / sponsor ID
- IUTIC / CCER 2023-00332
- Conditions
- Urinary Tract Infection(UTI), Urinary Tract Infection, Recurrent, UTI - Urinary Tract Infection
- Keywords
- uti, cohort, urinary tract infections, observational cohort
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Angela HUTTNERUniversity, hospital or other
- Collaborators
- University Hospital, Geneva
- Study start
- 6 Jun 2023 (actual)
- Primary completion
- Dec 2028 (estimated)
- Study completion
- Jan 2029 (estimated)
- First posted
- 20 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this prospective observational study is to collect epidemiological, clinical, microbiological, genetic, and behavioral data on individuals with UTIs. The goal is to better understand which interventions are effective and, subsequently, to facilitate studies that will improve our understanding of the condition, enhance patient care and relief, and help combat antimicrobial resistance. This project will enable us to study episodes of urinary tract infections over a period of at least 2 years and up to 5 years.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All patients of any age or disposition (in- or outpatient) with a history of, or active, urinary symptoms suggestive of UTI or diagnosed with UTI are eligible for inclusion into SUTIC. Adult (≥18 years) sexual partners of included patients are also eligible.
Key inclusion criteria (1 listed)
- Urinary symptoms/signs suggestive of UTI (as determined by investigators), or a history of such symptoms/signs.
Key exclusion criteria (1 listed)
- Unwillingness to provide informed consent (for patients with capacity or for the representatives of those without capacity) and/or inability to provide informed consent (for patients without capacity and without representation).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Total number of suspected and microbiologically confirmed urinary tract infections.
Time frame: From enrollment for a minimum of two years and a maximum of five years, with data collection at regular time points (2 months, 6 months, 12 months, 18 and 24 months after enrollment)
Yearly incidence of suspected and microbiologically confirmed UTI at 12 months among all patients initially presenting with lower urinary tract symptoms (LUTS) or upper urinary tract symptoms (UUTS).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Urinary Tract Infection(UTI)
Active, not recruitingObservational study
Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR
Complicated Urinary Tract Infection
Recruiting
INterest of the Negative Predictive Value of Integrons in the reduCtion of Large Broad-spectrum anTibiotics Consumption for Urinary Tract infectionS
Drug Resistance, Microbial, Biomarkers
Not yet recruitingObservational study
Comparative Study of the Genomic Characteristics of Uropathogenic Escherichia Coli According to the Severity of Community-Acquired Urinary Tract Infections in Guadeloupe (COLIGENURI)
Urinary Tract Infections
RecruitingPhase 2
A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With Methenamine Hippurate Compared to the Standard of Care (Either Prophylactic (Low) Dose Antibiotic Treatment or Methenamine Hippurate) in Females With Chronic Urinary Tract Infection
Chronic Urinary Tract Infection
Active, not recruitingObservational study
Characterization of Vaginal, Urinary and Fecal Microbiomes in Women With Recurrent Urinary Tract Infections
Urinary Tract Infections, Menopause
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Angela Huttner, MD principal investigator
Geneva University Hospitals, Geneva Faculty of Medicine
5 sites in 3 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Urinary Tract Infection(UTI) and Urinary Tract Infection, Recurrent, run by Angela HUTTNER at 5 sites in 3 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 20 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 5 sites in Switzerland, Germany, Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Total number of suspected and microbiologically confirmed urinary tract infections. (time frame: From enrollment for a minimum of two years and a maximum of five years, with data collection at regular time points (2 months, 6 months, 12 months, 18 and 24 months after enrollment)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2026.